Evidence map›Paper›PMID 38283558›Full record

ReviewKardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery2023

Radiotherapy for tumors of the mediastinum - state of the art.

Ioanna Kantzou, Georgios Sarris, Vasileios Kouloulias, Ioannis Abatzoglou, Vasileios Leivaditis, Konstantinos Grapatsas, Efstratios Koletsis, Athanasios Papatriantafyllou, Manfred Dahm, Admir Mulita and 2 more

Abstract readReview
In one paragraph

Review in Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ioanna KantzouFirst Department of Radiotherapy, 'Metaxa' Cancer Hospital, Piraeus, Greece.
Georgios SarrisFirst Department of Radiotherapy, 'Metaxa' Cancer Hospital, Piraeus, Greece.
Vasileios KoulouliasSecond Department of Radiology, 'Attikon' University Hospital, Athens, Greece.
Ioannis AbatzoglouMedical Physics Department, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Vasileios LeivaditisDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, Germany.
Konstantinos GrapatsasDepartment of Thoracic Surgery and Thoracic Endoscopy, University Medicine Essen - Ruhrland Clinic, Essen, Germany.
Efstratios KoletsisDepartment of Cardiothoracic Surgery, University Hospital of Patras, Patras, Greece.
Athanasios PapatriantafyllouDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, Germany.
Manfred DahmDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, Germany.
Admir MulitaMedical Physics Department, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Francesk MulitaDepartment of Surgery, University Hospital of Patras, Patras, Greece.
Nikolaos BaltayiannisDepartment of Thoracic Surgery, 'Metaxa' Cancer Hospital, Piraeus, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mediastinal tumors encompass a diverse range of malignancies, originating within or spreading to the mediastinum. The administration of radiotherapy within the anatomical confines of the mediastinum presents unique challenges owing to the close proximity of critical organs, including the heart, lungs, esophagus, and spinal cord. However, recent progress in imaging techniques, treatment modalities, and our understanding of tumor biology has significantly contributed to the development of effective and safe therapeutic strategies for mediastinal diseases. This review article aims to explore the latest innovations in radiotherapy and their practical applications in the management of mediastinal tumors, with a primary focus on lymphomas, thymomas, and thymic carcinomas. By examining these advancements, we seek to provide valuable insights into the current state of the art in radiotherapy for mediastinal malignancies, ultimately fostering improved patient outcomes and clinical decision-making.

Indexed as

lymphomamediastinumprimary tumorsradiotherapythymic carcinomathymoma

Identifiers

PMID38283558
PMCPMC10809816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.